IP Library Granted Patent US 9,629,793
Granted Patent B2
US 9,629,793 · App. 13/902,192 · Granted Apr 25, 2017

Topical skin care formulations comprising botanical extracts

Inventors: Tiffany Florence (Dallas, TX); David Gan (Southlake, TX); Michelle Hines (Hickory Creek, TX)
Assignee: Mary Kay Inc.
A61K8/97A61K36/24A61K36/62A61Q19/00A61Q19/007A61Q19/08A61Q19/10
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,629,793
App. No.
13/902,192
Granted
Apr 25, 2017
Kind
B2
Abstract

Disclosed is a topical skin composition comprising an aqueous extract from a part of Nymphaea gigantea , wherein said part consists of the flower of Nymphaea gigantea , an aqueous extract from a part of Plumeria alba , wherein said part consists of the flower of Plumeria alba , and a dermatologically acceptable vehicle.

Claims (22)

1. A method of treating skin by reducing elastin, reducing TNF-α, and/or inhibiting MMP-1 in skin of a subject in need thereof comprising topically applying to skin in need thereof a topical skin composition comprising:

an effective amount of an aqueous extract of Nymphaea gigantea flower;

an effective amount of an aqueous extract of Tristaniopsis laurina leaf;

an effective amount of an aqueous extract of Eucalyptus coolabah leaf; and

a dermatologically acceptable vehicle.

2. The method of claim 1 , wherein the composition comprises 0.01% to 20% by weight of said Nymphaea gigantea flower extract, 0.01% to 20% by weight of said Tristaniopsis laurina leaf extract, and 0.01% to 20% by weight of said Eucalyptus coolabah leaf extract.

3. The method of claim 2 , wherein the composition comprises at least 2% by weight of a combination of said Nymphaea gigantea flower extract, said Tristaniopsis laurina leaf extract, and said Eucalyptus coolabah leaf extract.

4. The method of claim 2 , wherein the composition further comprises a moisturizing agent or a humectant.

5. The method of claim 4 , wherein the composition comprises at least 50% by weight of water.

6. The method of claim 5 , wherein the Nymphaea gigantea flower extract, the Tristaniopsis laurina leaf extract, and the Eucalyptus coolabah leaf extract further comprise butylene glycol.

7. The method of 6 , wherein the composition is a lotion, cream, gel, serum, or emulsion.

8. The method of claim 1 , wherein the composition is a cosmetic product, and wherein the cosmetic product is a cleanser, a toner, a moisturizer, or a mask.

9. The method of claim 1 , wherein the dermatologically acceptable vehicle comprises water, glycerin, butylene glycol, phenoxyethanol, and potassium sorbate.

10. The method of claim 1 , wherein the composition is applied to fine lines or wrinkles.

11. The method of claim 1 , wherein the composition is applied to erythemic, sensitive, or inflamed skin.

12. The method of claim 1 , wherein the composition is applied to dry, flaky, or itchy skin.

13. The method of claim 1 , wherein the dermatologically acceptable vehicle comprises water, dimethicone, triethanolamine, and betaine.

14. The method of claim 1 , wherein the dermatologically acceptable vehicle comprises water, glycerin, pentylene glycol, and capryl glycol.

15. The method of claim 1 , wherein the dermatologically acceptable vehicle comprises water, glycerin, capryl glycol, and petrolatum.

16. The method of claim 1 , wherein the dermatologically acceptable vehicle comprises water, xanthan gum, pentylene glycol, and capryl glycol.

17. The method of claim 1 , wherein the dermatologically acceptable vehicle comprises water, citric acid, sodium cocoamphodiacetate, and sodium methyl cocoyl taurate.

18. The method of claim 1 , wherein the method treats skin by reducing elastin, reducing TNF-α, and inhibiting MMP-1.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 13, 2017
From: FLORENCE, TIFFANY; GAN, DAVID; HINES, MICHELLE
To: MARY KAY INC.
Reel/Frame 041000/0053 →
Continuity (4)
Continuation 13431712 · Mar 27, 2012
Continuation 12855391 · Aug 12, 2010
Provisional Application 61234115 · Aug 14, 2009
Related Publication 20130266677A1 · Oct 10, 2013